Wednesday, 10 August, 2022

Topic: Vaccine

ICMR studying BCG vaccine for Covid-19, won’t advise without enough evidence: Top scientist

ICMR scientist Nivedita Gupta says task force discussed using BCG to build immunity among at-risk groups, but there’s ‘miniscule’ evidence of its efficacy.

Coronavirus death toll crosses 10,000 in US, country enters ‘most difficult phase’

In New York, the epicenter of COVID-19 in US, the fatalities Monday increased to 4,758 and confirmed cases to 130,000.

Most vaccines go through years of tests, 12-18 months would be extraordinarily fast: Experts

Vaccine specialists this time are turning to technology aimed at speeding up a process that has traditionally taken 10 years or more.

Should we use masks to protect against Covid-19 and where do migrant workers go next

In episode 431 of #CutTheClutter, Shekhar Gupta discuses new evidence on face masks, the efficiency of BCG vaccine and continuing troubles of migrant workers in India.

Around 5,000 volunteers sign up for phase 1 clinical trial of covid-19 vaccine in Wuhan

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine will be tested in healthy adults aged between 18 and 60 years.

100-year-old TB vaccine now being tested for Covid-19, India may conduct a trial too

BCG vaccine could strengthen immunity against diseases other than TB, which could come as a relief to healthcare workers dealing with the coronavirus threat.

European registry of patients to contact tracing app — 5 global developments on COVID-19

From 3D map of SARS-CoV-2 proteins to more testing labs, ThePrint brings you the top coronavirus research developments from across the world.

10 reasons why you don’t need to panic about coronavirus

News updates about coronavirus are daunting but there are causes for optimism; reasons to think there may be ways to contain and defeat the virus.

MK Bhan — the warm and helpful scientist behind India’s rotavirus vaccine

Ex-secretary, Department of Biotechnology, Dr M.K. Bhan, widely known for making India’s first indigenous vaccine possible, was suffering from cancer & died Sunday.

These forgotten women played a huge role in eradicating smallpox from India

These women had to prove themselves in the hyper-masculine world of international public health.

On Camera


File photo of Sterlite copper unit at Tuticorin in Tamil Nadu | By special arrangement

Shut since 2018 violence, TN Sterlite plant’s closure cost economy Rs 14,749 cr, says study

Copper plant in Thoothukudi was closed after protests turned violent & police firing left 13 people dead. Job losses one of major impacts, says study by NGO CUTS International.


Representational image | Indian Army soldiers during the Army Day Parade at Cariappa Parade Ground in New Delhi | ANI Photo

Army looks to reduce troops by 2 lakh, deployment in Kashmir could be rejigged

The Army, which faces a shortage of about 1.35 lakh personnel, is aiming to reduce its strength from 12.8 lakh to around 10.8 lakh.

In Kashmir 3 years on, 3 positive changes, 3 things that should’ve happened & 3 that got worse

Kashmir as a crisis has fallen off our headlines and from the top of our collective minds. Which is precisely the most important change for the better.